Mather Group’s DexCom DXCM Stock Holding History

Mather Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$48.6K	Buy	563 +122	+28%	+$10.2K	﹤0.01%	1172
2026 Q2	$29.7K	Sell	441 -587	-57%	-$39.1K	﹤0.01%	1240
2026 Q1	$64.6K	Buy	+1,028	New	+$71.6K	﹤0.01%	1000
2025 Q4	–	Sell	-681	Closed	-$45.8K	–	919
2025 Q3	$45.8K	Buy	+681	New	+$53.9K	﹤0.01%	923
2025 Q2	–	Sell	-1,109	Closed	-$75.7K	–	915
2025 Q1	$75.7K	Buy	1,109 +638	+135%	+$52.1K	﹤0.01%	821
2024 Q4	$36.6K	Buy	471 +59	+14%	+$4.37K	﹤0.01%	936
2024 Q3	$27.6K	Sell	412 -851	-67%	-$69.9K	﹤0.01%	996
2024 Q2	$175K	Buy	1,263 +378	+43%	+$47.8K	﹤0.01%	648
2024 Q1	$110K	Buy	+885	New	+$111K	﹤0.01%	679
2022 Q1	–	Sell	-2,136	Closed	-$287K	–	453
2021 Q4	$287K	Buy	+2,136	New	+$307K	0.01%	304

Other funds holding DXCM

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Beacon Investment Advisory Services Morristown, New Jersey $2.66B AUM 29.77% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.04B AUM 19.97% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Mather Group's DXCM Position: Q3 2026 in Review

Mather Group increased its DexCom (DXCM) stake by 28% in Q3 2026, buying an estimated $10.2K and bringing the position to 563 shares worth $48.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Mather Group first reported a position in DXCM in Q4 2021 and has held it in 10 quarters since. The position peaked at $287K in Q4 2021. 205 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

Mather Group held 563 shares of DexCom worth $48.6K as of Q3 2026.
Mather Group bought 122 DexCom shares in Q3 2026, an estimated $10.2K.
DexCom made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1172 holding.
Mather Group first reported a position in DexCom in Q4 2021 and has held it in 10 quarters since.
Mather Group's DexCom position peaked at $287K in Q4 2021.
205 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.